{"id":"W2794447083","doi":"10.1002/14651858.cd012990.pub2","title":"GLP-1 receptor agonists for Parkinson's disease","year":2020,"lang":"en","type":"review","venue":"Cochrane Database of Systematic Reviews","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"","keywords":"Exenatide; Medicine; Dulaglutide; Placebo; Internal medicine; Cochrane Library; Clinical trial; Glucagon-like peptide 1 receptor; Oncology; Type 2 diabetes; Pharmacology; Diabetes mellitus; Agonist; Receptor; Endocrinology; Randomized controlled trial; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00169131,0.0009009777,0.01178205,0.0002180361,0.00006002161,0.00004556572,0.00051409,0.0001256298,0.0002286628],"category_scores_gemma":[0.003103431,0.0005542565,0.00257667,0.0004234801,0.00007106844,0.0001064961,0.0001846659,0.0001719562,0.001167331],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001779225,"about_ca_system_score_gemma":0.0003030642,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002168745,"about_ca_topic_score_gemma":5.966475e-7,"domain_scores_codex":[0.9943823,0.0005661818,0.003245194,0.0008371022,0.0005767569,0.0003924287],"domain_scores_gemma":[0.9938565,0.0006705949,0.002485247,0.002273821,0.0001518019,0.0005620262],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002363452,0.0001840963,6.899388e-7,0.8152655,0.0008159465,0.00004412654,0.00001377781,4.536009e-9,4.31057e-7,0.0002620183,0.05406871,0.1293211],"study_design_scores_gemma":[0.0003724891,0.00008979394,9.525054e-8,0.4748282,0.01619407,0.000005637399,0.000005249418,0.000003894079,3.709949e-7,0.000001652066,0.5082916,0.0002069043],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[8.358422e-8,0.9608858,0.0003356015,0.0001084515,0.0005347303,0.03587164,0.001850707,0.00006152225,0.0003514957],"genre_scores_gemma":[2.015857e-7,0.9700236,0.003666202,0.0001261353,0.0003415325,0.01173279,0.01212794,0.0001198881,0.001861715],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4542229,"threshold_uncertainty_score":0.9996909,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1120242106488102,"score_gpt":0.3802424003379355,"score_spread":0.2682181896891253,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}